- Impact of Acute Renal Failure on the Relationship between N-Terminal pro-B-Type Natriuretic Peptide and Hemodynamic Parameters2011 | First Faculty of Medicine, Third Faculty of Medicine
- N-terminal pro-B-type Natriuretic Peptide in three different mechanisms of dysnatremia onset after a child's craniopharyngioma surgery2017 | Central Library of Charles University
- Increased serum level of N-terminal Pro-B-type natriuretic peptide as a possible biomarker of cardiovascular risk in psoriatic patients2015 | Second Faculty of Medicine
- Monitoring trends in N-terminal pro-B-type natriuretic peptide (NT-proBNP) in acute brain disease2010 | First Faculty of Medicine
- Prognostic value of N-Terminal pro-B-type natriuretic peptide in patients with severe acute decompensated heart failure +12008 | Faculty of Medicine in Hradec Králové
- Prognostic value of N-terminal pro B-type natriuretic peptide, cytokines and sCD40L in patients with acute heart failurePublication without faculty affiliation
- Prognostic value of N-Terminal pro-B-type natriuretic peptide in patients with severe acute decompensated heart failure2008 | First Faculty of Medicine
- N - terminal pro B - type natriuretic peptide as prognostic marker in conorary patients without clinically manifest heart failure2009 | Central Library of Charles University
- N - terminal pro B - type natriuretic peptide as prognostic marker in conorary patients without clinically manifest heart failure2009 | Faculty of Medicine in Pilsen
- N - terminal pro B - type natriuretic peptide as prognostic marker in conorary patients without clinically manifest heart failure2009 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide2009 | First Faculty of Medicine
- Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy2021 | First Faculty of Medicine
- Role of biomarkers of cardiac remodeling, myofibrosis, and inflammation in assessment of disease severity in euvolemic patients with chronic stable heart failure2020 | Third Faculty of Medicine
- Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure2023 | First Faculty of Medicine
- Exercise dynamics of cardiac biomarkers and hemoconcentration in patients with chronic systolic heart failure2020 | First Faculty of Medicine
- NT-proBNP predicts mortality in adults with transposition of the great arteries late after Mustard or Senning correction2017 | Publication without faculty affiliation
- Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial2022 | First Faculty of Medicine
- Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure2015 | First Faculty of Medicine
- Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan2018 | First Faculty of Medicine
- Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study2020 | First Faculty of Medicine
- Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study2021 | First Faculty of Medicine
- Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial2018 | First Faculty of Medicine
- Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes2020 | First Faculty of Medicine